Enliven Therapeutics is a biopharmaceutical company that develops small molecule inhibitors to improve the lives of cancer patients. They use a precision oncology approach to address unmet needs and enhance patient well-being. Their discovery process combines validated biological targets and unique chemistry to create innovative therapies.